Phenylpyruvate (PPA)

Phenylpyruvate is an alpha-keto acid that serves as a key metabolic intermediate in the catabolism of the essential amino acid phenylalanine (PubChem CID 49). Under normal physiological conditions, phenylalanine is primarily converted to tyrosine by phenylalanine hydroxylase; however, when this pathway is saturated or deficient, phenylalanine undergoes transamination to form phenylpyruvate (HMDB0000213). This molecule is the hallmark metabolite of Phenylketonuria (PKU), a genetic disorder where the accumulation of phenylpyruvate and its derivatives in the blood and urine leads to severe neurotoxicity and intellectual disability if left untreated (StatPearls, "Phenylketonuria"). While phenylpyruvate is not a traditional therapeutic target for drug binding, its detection is critical for the diagnosis and monitoring of metabolic disorders (PubMed, PMID: 31054518). Current pharmacological interventions focus on reducing the levels of its precursor, phenylalanine, rather than interacting directly with phenylpyruvate itself.

Other names

Phenylpyruvic acid2-Oxo-3-phenylpropanoic acidalpha-Oxohydrocinnamic acid3-Phenyl-2-oxopropanoic acidBenzene-pyruvic acid

Phenylpyruvate is a metabolic byproduct rather than a therapeutic target; drugs in this disease space target upstream enzymes like Phenylalanine hydroxylase or degrade the precursor Phenylalanine.